- Ownership hops held
- 1000
An absent edge means not yet observed — never does not exist.
Contineum Therapeutics, Inc.
Contineum Therapeutics, Inc. — US company (sec:0001855175). UBO chain traced 1000 hops, 11 owners. Every claim linked to its source.
Ownership resolves 1000 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- Contineum Therapeutics, Inc.
None in current sources.
1000-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.
Everything we hold on Contineum Therapeutics, Inc., resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €149.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBOSTANDARD
- Full export (PDF + un-redacted JSON) & change alertsPREMIUM
People & control
21 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- Boyce SarahAlso holds roles at 10 other companies
- Avidity Biosciences, Inc.officer
- Avidity Biosciences, Inc.director
- ATRIUM THERAPEUTICS, INC.director
- Ignelzi Troy A.Also holds roles at 6 other companies
- Rapport Therapeutics, Inc.officer
- Harmony Biosciences Holdings, Inc.director
- KARUNA THERAPEUTICS, INC.officer
- JOHNSON & JOHNSONAlso holds roles at 92 other companies
- Duato Joaquinofficer
- HEWSON MARILLYN Adirector
- Woods Eugene A.director
- JOHNSON & JOHNSON DEVELOPMENT CORP ET ALAlso holds roles at 14 other companies
- CVRx, Inc.tenpercentowner
- MeiraGTx Holdings plctenpercentowner
- FUSION PHARMACEUTICALS INC.tenpercentowner
- LYONS-WILLIAMS LORIAlso holds roles at 3 other companies
- RAPT Therapeutics, Inc.director
- FIVE PRIME THERAPEUTICS INCdirector
- DERMIRA, INC.officer
- Miralles Gines DiegoAlso holds roles at 3 other companies
- Artiva Biotherapeutics, Inc.officer
- Artiva Biotherapeutics, Inc.director
- BBM HOLDINGS, INC.director
- Schimmelpennink Evert B.Also holds roles at 5 other companies
- LENZ Therapeutics, Inc.officer
- LENZ Therapeutics, Inc.director
- iBio, Inc.director
- Slover Peter TAlso holds roles at 2 other companies
- SOPHIRIS BIO INC.officer
- ANADYS PHARMACEUTICALS INCofficer
- VERSANT SIDE FUND IV, L.P.Also holds roles at 7 other companies
- Tempest Therapeutics, Inc.tenpercentowner
- OYSTER POINT PHARMA, INC.tenpercentowner
- Inari Medical, Inc.tenpercentowner
- Versant Vantage I GP-GP, LLCAlso holds roles at 9 other companies
- LAVA Therapeutics NV10% owner
- LAVA Therapeutics NVtenpercentowner
- Monte Rosa Therapeutics, Inc.tenpercentowner
- Versant Vantage I GP, L.P.Also holds roles at 9 other companies
- LAVA Therapeutics NV10% owner
- LAVA Therapeutics NVtenpercentowner
- Monte Rosa Therapeutics, Inc.tenpercentowner
- Versant Vantage I, L.P.Also holds roles at 11 other companies
- LAVA Therapeutics NV10% owner
- LAVA Therapeutics NVtenpercentowner
- Monte Rosa Therapeutics, Inc.tenpercentowner
- VERSANT VENTURE CAPITAL IV, L.P.Also holds roles at 8 other companies
- Tempest Therapeutics, Inc.tenpercentowner
- OYSTER POINT PHARMA, INC.tenpercentowner
- Inari Medical, Inc.tenpercentowner
- Versant Venture Capital VI, L.P.Also holds roles at 13 other companies
- LAVA Therapeutics NV10% owner
- LENZ Therapeutics, Inc.tenpercentowner
- LAVA Therapeutics NVtenpercentowner
- VERSANT VENTURES IV, LLCAlso holds roles at 8 other companies
- Tempest Therapeutics, Inc.tenpercentowner
- OYSTER POINT PHARMA, INC.tenpercentowner
- Inari Medical, Inc.tenpercentowner
- Versant Ventures VI GP-GP, LLCAlso holds roles at 11 other companies
- LAVA Therapeutics NV10% owner
- LENZ Therapeutics, Inc.tenpercentowner
- LAVA Therapeutics NVtenpercentowner
- Versant Ventures VI GP, L.P.Also holds roles at 11 other companies
- LAVA Therapeutics NV10% owner
- LENZ Therapeutics, Inc.tenpercentowner
- LAVA Therapeutics NVtenpercentowner
- Ware Olivia CAlso holds roles at 3 other companies
- Revance Therapeutics, Inc.director
- Arcellx, Inc.director
- CYTRX CORPofficer
21 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns Contineum Therapeutics, Inc.?
- What is Contineum Therapeutics, Inc.'s risk level?
- Where does Contineum Therapeutics, Inc. appear across sources?